Pagano R E, Sepanski M A, Martin O C
Department of Embryology, Carnegie Institution of Washington, Baltimore, Maryland 21210-3301.
J Cell Biol. 1989 Nov;109(5):2067-79. doi: 10.1083/jcb.109.5.2067.
We have previously shown that a fluorescent derivative of ceramide, N-(epsilon-7-nitrobenz-2-oxa-1,3-diazol-4-yl-aminocaproyl)-D-eryth ro-sphingosin e (C6-NBD-Cer), vitally stains the Golgi apparatus of cells (Lipsky, N. G., and R. E. Pagano. 1985. Science (Wash. DC). 228:745-747). In the present paper we demonstrate that C6-NBD-Cer also accumulates at the Golgi apparatus of fixed cells and we explore the mechanism by which this occurs. When human skin fibroblasts were fixed with glutaraldehyde and then incubated with C6-NBD-Cer at 2 degrees C, the fluorescent lipid spontaneously transferred into the cells, labeling the Golgi apparatus as well as other intracellular membranes. Subsequent incubations with defatted BSA at 24 degrees C removed excess C6-NBD-Cer from the cells such that fluorescence was then detected only at the Golgi apparatus. Similar results were obtained using other cell types. A method for visualizing the fluorescent lipid at the electron microscopic level, based on the photoconversion of a fluorescent marker to a diaminobenzidine product (Sandell, J. H., and R. H. Masland, 1988. J. Histochem. Cytochem. 36:555-559), is described and evidence is presented that C6-NBD-Cer was localized to the trans cisternae of the Golgi apparatus. While accumulation occurred in cells fixed in various ways, it was inhibited when fixation protocols that extract or modify cellular lipids were used. In addition, Filipin, which forms complexes with cellular cholesterol, labeled the Golgi apparatus of fixed cells and inhibited accumulation of C6-NBD-Cer at the Golgi apparatus. These results are discussed in terms of a simple model based on the physical properties of C6-NBD-Cer and its interactions with endogenous lipids of the Golgi apparatus. Possible implications of these findings for metabolism and transport of (fluorescent) sphingolipids in vivo are also presented.
我们之前已经表明,神经酰胺的一种荧光衍生物,N-(ε-7-硝基苯并-2-恶唑-1,3-二氮杂环丁烷-4-基-氨基己酰基)-D-赤藓糖神经鞘氨醇(C6-NBD-Cer),能够对细胞的高尔基体进行活体染色(Lipsky, N. G., and R. E. Pagano. 1985. Science (Wash. DC). 228:745-747)。在本文中,我们证明C6-NBD-Cer也会在固定细胞的高尔基体中积累,并且我们探究了这种现象发生的机制。当用人皮肤成纤维细胞用戊二醛固定,然后在2℃下与C6-NBD-Cer孵育时,荧光脂质会自发转移到细胞内,标记高尔基体以及其他细胞内膜。随后在24℃下用脱脂牛血清白蛋白孵育可去除细胞中多余的C6-NBD-Cer,使得随后仅在高尔基体处检测到荧光。使用其他细胞类型也获得了类似的结果。本文描述了一种基于荧光标记物向二氨基联苯胺产物的光转化在电子显微镜水平可视化荧光脂质的方法(Sandell, J. H., and R. H. Masland, 1988. J. Histochem. Cytochem. 36:555-559),并提供了证据表明C6-NBD-Cer定位于高尔基体的反式潴泡。虽然在以各种方式固定的细胞中都会发生积累,但当使用提取或修饰细胞脂质的固定方案时,积累会受到抑制。此外,与细胞胆固醇形成复合物的制霉菌素标记了固定细胞的高尔基体,并抑制了C6-NBD-Cer在高尔基体处的积累。这些结果将根据基于C6-NBD-Cer的物理性质及其与高尔基体的内源性脂质相互作用的简单模型进行讨论。还介绍了这些发现对体内(荧光)鞘脂代谢和运输的可能影响。